The irreversible component of persistent asthma - PubMed (original) (raw)

Review

The irreversible component of persistent asthma

Rodolfo M Pascual et al. J Allergy Clin Immunol. 2009 Nov.

Abstract

Irreversible airflow obstruction or limitation occurs in some patients with asthma, can develop early in life, and becomes more common as asthma becomes more severe. Efforts to understand irreversible airflow obstruction or limitation have been hampered by the lack of a standardized definition of the phenotype and by the lack of appropriate research models. Unfortunately, it appears that currently available asthma treatments do not prevent this important asthma complication. Herein, the evidence of an irreversible component of asthma, its underlying pathology, and the limitations of current asthma treatments are reviewed.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Orie NG, Sluiter-Eringa H, de VK. The Host Factor in Bronchitis. In: Orie NG, Sluiter-Eringa H, editors. Bronchitis. Assen, Netherlands: Royal van Gorcum; 1961. pp. 43–59.
    1. Panettieri RA, Jr, Covar R, Grant E, Hillyer EV, Bacharier L. Natural history of asthma: persistence versus progression-does the beginning predict the end? J Allergy Clin Immunol. 2008;121(3):607–13. - PubMed
    1. Broide DH. Immunologic and inflammatory mechanisms that drive asthma progression to remodeling. J Allergy Clin Immunol. 2008;121(3):560–70. - PMC - PubMed
    1. Spahn JD, Covar R. Clinical assessment of asthma progression in children and adults. J Allergy Clin Immunol. 2008;121(3):548–57. - PubMed
    1. Boulet LP, Sterk PJ. Airway remodelling: the future. Eur Respir J. 2007;30(5):831–4. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources